Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

New methods efficiently isolate dermal papilla cells from hair follicles, preserving their characteristics better than traditional methods.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

A standardized guideline would improve Telogen Effluvium management.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.

FAGA shows varied hair thickness, while TE has more empty follicles.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Low iron levels may be linked to some types of hair loss in women.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.